Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduodenectomy outcomes. Takamoto T, Nara S, Ban D, Mizui T, et al. Surgery 2024;180:109026.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takamoto T, Nara S, Ban D, Mizui T, et al. Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduodenectomy outcomes. Surgery 2024;180:109026.
PMID: 39740600